About the JSHT

Message From The Chairman

We began in 1990 as a research group concerned with hereditary colorectal cancer, and after our group was re-established as the Japanese Study Group of Familial Tumors in 1994, then as the Japanese Society of Familial Tumors in 2005 (incorporated in 2016), we made a new start in 2019 as the Japanese Society for Hereditary Tumors.

The primary goal of the JSHT’s activities is to contribute to the medical care, education, and research related to all hereditary tumors and diseases. Conferences held by the JSHT, which focus on hereditary tumors and related diseases, are among the few opportunities worldwide for clinicians, basic researchers, nurses, genetic counselors, and other related medical staff in this field to meet and work closely together in the furtherance of their discipline. The recent, rapid progress made in Japan in cancer genomic medicine and genetic diagnosis, the introduction of insurance coverage for HBOC treatments, and the clinical introduction of highly effective drug therapies for hereditary tumors have encouraged broad support for our society’s efforts to promote correct understanding of hereditary tumors and their medical care. As a result of our activities, the Society’s membership exceeded 2,200 in August 2023 and continues to grow.

In addition to its 18 standing committees, the JSHT has established subcommittees to promote appropriate medical care for hereditary tumors and has fostered a team of hereditary tumor specialists and coordinators. Since June 2020, the JSHT has been strengthening its management system and financial base, conducting a fundamental review of the organization of its scientific meetings, collaborating closely with standing committees, and promoting its collaboration with related societies worldwide, including those concerned with genetic medicine and clinical oncology.

To maintain this course of development, the JSHT increased its number of directors and auditors. In June 2022, the Board of Directors grew to include 15 directors and 3 auditors. Also, in 2025, a new management system will be established to enable the trustees to be elected under a new electoral system.

2023 August